Clinical trial
Effects of Memantine on Cognitive Disorders of Relapsing-remitting Multiple Sclerosis
NCT01074619 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Memantine on Cognitive Disorders of Relapsing-remitting Multiple Sclerosis
- Lead sponsor
- University Hospital, Caen
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2005
- Completion date
- November 30, 2011
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.